Lidia Fonseca is a director of TEGNA Inc.
Person profile
Address
Burlington, North Carolina
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Feb 24 | PFE Pfizer | Stock Appreciation Rights Common Stock | Grant | Acquire A | No | No | 26.89 | 60,124 | 1.62 mm | 60,124 |
27 Feb 24 | PFE Pfizer | Stock Appreciation Rights Common Stock | Grant | Acquire A | No | No | 26.89 | 68,045 | 1.83 mm | 68,045 |
1 May 23 | TGNA TEGNA | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,039.39 | 0.00 | 45,221.39 |
1 May 23 | TGNA TEGNA | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 6,039.39 | 0.00 | 0 |
1 May 23 | MDT Medtronic | Ordinary Shares | Grant | Acquire A | No | No | 90.68 | 1,624 | 147.26 k | 1,624 |
23 Feb 23 | PFE Pfizer | Stock Appreciation Rights Common Stock | Grant | Acquire A | No | No | 42.3 | 37,966 | 1.61 mm | 37,966 |
23 Feb 23 | PFE Pfizer | Stock Appreciation Rights Common Stock | Grant | Acquire A | No | No | 42.3 | 43,624 | 1.85 mm | 43,624 |